Lista de obras -

Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis

artículo científico publicado en 2019

Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient

artículo científico publicado en 2011

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS.

artículo científico publicado en 2005

Clinical and genetic determinants of nevirapine plasma trough concentration.

artículo científico publicado en 2018

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients

artículo científico publicado en 2011

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers

artículo científico publicado en 2014

Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid

Comparison of the Arktm Immunoassay With Hplc-Uv for Therapeutic Drug Monitoring of Linezolid

artículo científico publicado en 2017

Comparison of the QMS Analyzer With HPLC-UV for the Quantification of Lamotrigine Concentrations in Human Plasma Samples

artículo científico publicado en 2015

Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing

artículo científico publicado en 2012

Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection

artículo científico publicado en 2010

Development and Validation of a Chromatographic Ultraviolet Method for the Quantification of Isavuconazole in Human Plasma Samples

artículo científico publicado en 2018

Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma

artículo científico publicado en 2016

Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients

artículo científico publicado en 2016

Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?

artículo científico publicado en 2016

Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference

artículo científico publicado en 2017

Exposure-related effects of atazanavir on the pharmacokinetics of raltegravir in HIV-1-infected patients

artículo científico publicado en 2010

Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review

artículo científico publicado en 2020

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects

artículo científico publicado en 2011

Is it time to revise antiretrovirals dosing? a pharmacokinetic viewpoint

artículo científico publicado en 2014

Is it time to revise linezolid doses in peritoneal dialysis patients? A case series

artículo científico publicado en 2015

Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients

artículo científico publicado en 2011

Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients.

artículo científico publicado en 2011

Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections

artículo científico publicado en 2013

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

artículo científico publicado en 2015

Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals

artículo científico publicado en 2004

Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.

artículo científico publicado en 2003

Pharmacogenetics-based optimisation of atazanavir treatment: potential role of new genetic predictors.

artículo científico publicado en 2017

TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents

artículo científico publicado en 2006

Therapeutic drug management of linezolid: a missed opportunity for clinicians?

artículo científico publicado en 2016

Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis

scientific article published on 01 October 2019

Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding.

artículo científico publicado en 2010

Lista de obras de

Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis

Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS.

Clinical and genetic determinants of nevirapine plasma trough concentration.

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers

Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid

Comparison of the Arktm Immunoassay With Hplc-Uv for Therapeutic Drug Monitoring of Linezolid

Comparison of the QMS Analyzer With HPLC-UV for the Quantification of Lamotrigine Concentrations in Human Plasma Samples

Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing

Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection

Development and Validation of a Chromatographic Ultraviolet Method for the Quantification of Isavuconazole in Human Plasma Samples

Development and Validation of a Chromatographic Ultraviolet Method for the Simultaneous Quantification of Dolutegravir and Rilpivirine in Human Plasma

Development of an HPLC-UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients

Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?

Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference

Exposure-related effects of atazanavir on the pharmacokinetics of raltegravir in HIV-1-infected patients

Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects

Is it time to revise antiretrovirals dosing? a pharmacokinetic viewpoint

Is it time to revise linezolid doses in peritoneal dialysis patients? A case series

Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients

Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients.

Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals

Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.

Pharmacogenetics-based optimisation of atazanavir treatment: potential role of new genetic predictors.

TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents

Therapeutic drug management of linezolid: a missed opportunity for clinicians?

Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis

Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding.